Key result
Glycemic control and aggressive secondary prevention lower mortality and morbidity in diabetes and ACS.
Why the study?
Diabetes is a leading risk factor for acute coronary syndromes with increased mortality and morbidity, often presenting atypically due to autonomic neuropathy.
Highlights the importance of aggressive secondary prevention and the central role of cardiovascular nurses in managing patients with diabetes and acute coronary syndromes.
Answers are grounded in this paper and cite their sources.
Supports nurse-led secondary prevention in diabetes with ACS; leaves open dedicated RCTs to confirm outcome impact.
Diabetes is one of the leading risk factors for the development of acute coronary syndromes with an increased inherent risk for mortality and morbidity. Rather than the classic symptom of chest pain an atypical presentation or silent ischaemia is common. This atypical presentation can be attributed to the presence of autonomic neuropathy. Glycaemic control and evidence-based treatment strategies decrease this risk. Aside from acute management once stabilised secondary prevention should be aggressive with the aim of preventing future events. Cardiovascular nurses have a central role in the acute management and secondary prevention in this patient population.
No takes yet. Share an insight, caveat, or question.
Kate O’Donovan (2012) conducted a review in Diabetes and acute coronary syndromes. Glycaemic control and secondary prevention was evaluated. Glycaemic control and aggressive secondary prevention decrease the risk of mortality and morbidity in patients with diabetes and acute coronary syndromes.
Synapse has enriched 10 related papers. Consider them for comparative context: